PHARMACEUTICAL COMPOSITION CONTAINING URIDINE 5'-TRIPHOSPHATE FOR THE TREATMENT OF CYSTIC FIBROSIS
Uridine 5'-triphosphate, or a pharmaceutically acceptable salt thereof, is useful in the symptomatic treatment of cystic fibrosis when inhaled into the lungs. Suitable pharmaceutical compositions for use in such treatment include solutions for nebulization, non-pressurized powders and pressuriz...
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
09.07.1992
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Uridine 5'-triphosphate, or a pharmaceutically acceptable salt thereof, is useful in the symptomatic treatment of cystic fibrosis when inhaled into the lungs. Suitable pharmaceutical compositions for use in such treatment include solutions for nebulization, non-pressurized powders and pressurized aerosols.
L'uridine-5'-triphosphate, ou un sel pharmaceutiquement acceptable de celle-ci, est utile au traitement symptomatique de la mucoviscidose lorsqu'on l'aspire dans les poumons. Des compositions pharmaceutiques adaptées à ce traitement sont, par exemple, les solutions à nébuliser, les poudres non pressurisées et les aérosols sous pression. |
|---|---|
| AbstractList | Uridine 5'-triphosphate, or a pharmaceutically acceptable salt thereof, is useful in the symptomatic treatment of cystic fibrosis when inhaled into the lungs. Suitable pharmaceutical compositions for use in such treatment include solutions for nebulization, non-pressurized powders and pressurized aerosols.
L'uridine-5'-triphosphate, ou un sel pharmaceutiquement acceptable de celle-ci, est utile au traitement symptomatique de la mucoviscidose lorsqu'on l'aspire dans les poumons. Des compositions pharmaceutiques adaptées à ce traitement sont, par exemple, les solutions à nébuliser, les poudres non pressurisées et les aérosols sous pression. |
| Author | POLLARD, CHRISTOPHER, ERNEST JACKSON, DALE, MICHAEL |
| Author_xml | – fullname: JACKSON, DALE, MICHAEL – fullname: POLLARD, CHRISTOPHER, ERNEST |
| BookMark | eNqNjL0KwjAURjPo4N873M2pYBQFxxgTc8HmluQWcSpV4iRtob4_ZvABnM43nO_MxaTruzQTj8qpUCptakatrqCprCgiI_m8PSv06C9QBzyjN7BfFxywchTzjw1YCsDOAAejuDSegSzoe8wxsHgKORWXYvpq32Na_bgQYA1rV6Shb9I4tM_UpU9zo-NWyo08KLn7Q_kC_bc1rw |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | WO9211016A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_WO9211016A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 11:21:55 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_WO9211016A13 |
| Notes | Application Number: WO1991GB02299 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19920709&DB=EPODOC&CC=WO&NR=9211016A1 |
| ParticipantIDs | epo_espacenet_WO9211016A1 |
| PublicationCentury | 1900 |
| PublicationDate | 19920709 |
| PublicationDateYYYYMMDD | 1992-07-09 |
| PublicationDate_xml | – month: 07 year: 1992 text: 19920709 day: 09 |
| PublicationDecade | 1990 |
| PublicationYear | 1992 |
| RelatedCompanies | FISONS PLC |
| RelatedCompanies_xml | – name: FISONS PLC |
| Score | 2.4211762 |
| Snippet | Uridine 5'-triphosphate, or a pharmaceutically acceptable salt thereof, is useful in the symptomatic treatment of cystic fibrosis when inhaled into the lungs.... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | PHARMACEUTICAL COMPOSITION CONTAINING URIDINE 5'-TRIPHOSPHATE FOR THE TREATMENT OF CYSTIC FIBROSIS |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19920709&DB=EPODOC&locale=&CC=WO&NR=9211016A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFA9jinrTqTi_yEHqqei6trOHIV2a2gj9oM10nqTpMtilG67iv-9L2KYXvYWEPJJHXt5H3vsFoRtn6jjCsxyzqmbCtCvXMsv-QFWBzHr3Ygb3pv4lIk7caGw_T5xJC803tTAaJ_RLgyOCRFUg742-r5c_QaxA51au7sQcuhaPIR8GxnRdLmbBCfaMYDSkWRqkxCAE_DYjyYeecnR6rg-O0o6yohXMPn0ZqaKU5W-NEh6i3QyI1c0Rasm6g_bJ5uO1DtqL1-_d0FyL3uoYiSzy89gndMwVhAEmaZylBVMRJmgn3GcJS57wOGcBSyh2bk2esyxKC5jHKQZnD_OIYp5TnysAf5yGmLwVQAyHbJQDqeIE4ZByEpmw2PctY95f0-22-qeoXS9qeYawBBPD9gZSihIYXdoPrrRLofVOZVV9t4u6f5I5_2fsAh1sc1W9S9RuPj7lFWjkRlxrXn4DY2eIIg |
| link.rule.ids | 230,309,786,891,25594,76904 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH8haMSbokb87MHM06KMbbgDMaPrXJV9ZCuKJ7KOkXABIjP--74tgF701rTpS_vS19df-96vADfGxDCkpRlqlk2lqmempqadbpkFMm3fyynum9UvEX5gekP9eWSMajDb5MJUPKFfFTkiWlSG9l5U-_Xy5xLLqWIrV3dyhlWLR1f0HGWyThfTcAVbitPvsSh0QqpQirhNCeKeVQKdtmkjUNrpIiIsafbZa79MSln-9ijuAexGKGxeHEItnzehQTcfrzVhz1-_d2NxbXqrI5CRZ8e-TdlQlBQGhIZ-FCa8vGHCciBsHvDgiQxj7vCAEeNWFTGPvDDBfoIRBHtEeIyImNmiJPAnoUvoe4LCiMv7MYpKjoG4TFBPxcGOt4oZv4XbaXVOoD5fzPNTIDkeMXSrm-cyRUWn-oOZ66ms_E6mZR2zBa0_xZz903YNDU_4g_GABy_nsL-NW7UuoF58fOaX6J0LeVXp9RvmmIsN |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PHARMACEUTICAL+COMPOSITION+CONTAINING+URIDINE+5%27-TRIPHOSPHATE+FOR+THE+TREATMENT+OF+CYSTIC+FIBROSIS&rft.inventor=JACKSON%2C+DALE%2C+MICHAEL&rft.inventor=POLLARD%2C+CHRISTOPHER%2C+ERNEST&rft.date=1992-07-09&rft.externalDBID=A1&rft.externalDocID=WO9211016A1 |